|
Impact of telehealth legislation on gynecologic oncology services: Policy updates
|
February 14, 2025
|
PC3I Authors Lakeisha Mulugeta-Gordon; Emily Gleason; Anna Jo Smith; Emily Ko |
Gynecologic Oncology
|
|
Racial disparities in receipt of radiation and brachytherapy in cervical cancer patients: Do they exist in a SEER-Medicare population?
|
October 8, 2024
|
PC3I Authors Emily Gleason; Emily Ko |
Gynecologic oncology reports
|
|
Racial disparities in receipt of radiation and brachytherapy in cervical cancer patients and impact on survival outcomes: Do they exist in a SEER-Medicare population? (2124)
|
September 1, 2023
|
PC3I Authors Emily Gleason; Emily Ko |
Gynecologic Oncology
|
|
Cost of care associated with utilization of telehealth in clinical trials.
|
May 31, 2023
|
PC3I Authors Emily Gleason; Emily Ko |
Journal of Clinical Oncology
|
|
Telehealth utilization in gynecologic oncology clinical trials
|
September 2, 2023
|
PC3I Authors Emily Ko; Emily Gleason |
Gynecologic Oncology
|
|
Rideshare services for transportation assistance in gynecologic oncology: a quality improvement study
|
February 14, 2025
|
PC3I Authors Anna Jo Smith; Meredith Doherty; Justin Bekelman; Emily Ko |
BMC Health Services Research
|
|
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study
|
February 22, 2025
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
Early-career and fellow gynecologic oncologists perceive underpreparedness for the business of medicine: A Society of gynecologic oncology survey study
|
September 21, 2024
|
PC3I Authors Emily Ko |
Gynecologic Oncology Reports
|
|
Current diagnostic guidelines and perpetuation of inequities in ovarian cancer: A National Cancer Database study.
|
May 29, 2024
|
PC3I Authors Anna Jo Smith; Emily Gleason; Anne Marie McCarthy |
Journal of Clinical Oncology
|
|
Transportation assistance in gynecologic oncology: A pilot study.
|
October 26, 2023
|
PC3I Authors Anna Jo Smith; Emily Ko; Justin Bekelman |
JCO Oncology Practice
|
|
Addressing transportation barriers in oncology: existing programs and new solutions
|
April 29, 2024
|
PC3I Authors Emily Ko; Meredith Doherty; Anna Jo Smith |
Supportive Care in Cancer
|
|
“Having cancer is very expensive”: A qualitative study of patients with ovarian cancer and PARP inhibitor treatment
|
May 1, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko; Katharine Rendle |
Gynecologic Oncology
|
|
Ovarian Cancer Isn’t Just a White Woman’s Disease
|
April 4, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
JAMA Oncology
|
|
An SGO commentary: U.S. News and World Report gynecologic oncology procedural ratings-Do they reflect high-quality care?
|
March 16, 2024
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database
|
May 6, 2021
|
PC3I Authors Emily Ko |
Surgical Oncology
|
|
Minimally invasive hysterectomy for stage IA cervical carcinoma: a survival analysis of the National Cancer Database
|
May 8, 2021
|
PC3I Authors Emily Ko |
International Journal of Gynecological Cancer
|
|
Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis
|
May 31, 2021
|
PC3I Authors Emily Ko |
American Journal of Obstetrics and Gynecology
|
|
Outcomes of comprehensive lymphadenectomy for patients with advanced stage ovarian carcinoma and rare histologic sub-types
|
July 1, 2021
|
PC3I Authors Emily Ko |
International Journal of Gynecological Cancer
|
|
The oncology care model and the future of alternative payment models: A gynecologic oncology perspective
|
July 23, 2021
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer
|
October 27, 2021
|
PC3I Authors Emily Ko |
International Journal of Gynecological Cancer
|
